NCT01549041View on ClinicalTrials.gov

Once-Daily Asenapine for Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

November 30, 2013

Conditions
Schizophrenia
Interventions
DRUG

Asenapine 10 mg daily in the evening

The total daily dose of Asenapine will be given once daily in the evening

DRUG

Asenapine 5 mg twice daily

Asenapine will be given in two doses, 5 mg in the morning and 5 mg in the evening, daily

Trial Locations (1)

27609

Central Regional Hospital, Butner

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Duke University

OTHER